Cargando…
lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR-125a-5p
Development of resistance to endocrine therapy, such as tamoxifen, remains a tricky clinical problem during the treatment of breast cancer. Accumulating evidence suggested that dysregulation of long noncoding (lnc_RNAs contributes to the development of tamoxifen resistance. In the current study, via...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984795/ https://www.ncbi.nlm.nih.gov/pubmed/31894257 http://dx.doi.org/10.3892/ijmm.2019.4428 |